The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - GOG Partners
Consulting or Advisory Role - Varian Medical Systems
ROCC/GOG-3043: A randomized non-inferiority trial of robotic versus open radical hysterectomy for early-stage cervical cancer.
 
Kristin Leigh Bixel
Consulting or Advisory Role - Merck
Research Funding - Intuitive Surgical
 
Mario M. Leitao
Honoraria - Intuitive Surgical
Consulting or Advisory Role - Ethicon/Johnson & Johnson; Intuitive Surgical; Medtronic; Takeda
Research Funding - KCI
Travel, Accommodations, Expenses - Intuitive Surgical
 
Dana Meredith Chase
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Seagen
Speakers' Bureau - AstraZeneca; GlaxoSmithKline
 
Allison Quick
No Relationships to Disclose
 
Peter C Lim
Honoraria - Intuitive Surgical
Speakers' Bureau - Intuitive Surgical
Travel, Accommodations, Expenses - Intuitive Surgical
 
Ramez Nassef Eskander
Consulting or Advisory Role - Agenus; AstraZeneca/MedImmune; Clovis Oncology; Daiichi Sankyo/Lilly; Eisai; Merck; Myriad Genetics; Pfizer; Tesaro
Speakers' Bureau - AstraZeneca/MedImmune; Myriad Genetics
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Eisai; Merck
 
Walter H. Gotlieb
Honoraria - AstraZeneca; AstraZeneca; Intuitive Surgical; Merck; Minogue Medical; Pfizer; Roche Canada
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca (Inst); Intuitive Surgical (Inst)
Travel, Accommodations, Expenses - Minogue Medical
 
Salvatore LoCoco
No Relationships to Disclose
 
Martin A Martino
Consulting or Advisory Role - Ethicon/Johnson & Johnson; Intuitive Surgical; Medtronic
Speakers' Bureau - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Patent pending, software surgical tracker
Expert Testimony - Kiran Anthony, LLC
 
Colleen McCormick
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck
Speakers' Bureau - AstraZeneca
 
Tashanna K. N. Myers
Consulting or Advisory Role - Immunogen
 
Krishnansu Sujata Tewari
Honoraria - AstraZeneca; Clovis Oncology; Eisai; Genmab; Merck; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Genmab; Merck; Roche/Genentech; Tesaro
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Merck (Inst); Morphotek (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Brian M. Slomovitz
Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; Eisai; EQRx; Genentech; GlaxoSmithKline; GOG Foundation; Incyte; Merck; Myriad Genetics; Nuvation Bio; Onconova Therapeutics; Regeneron
 
Joan L. Walker
Research Funding - Genentech; Pieces Tech (Inst); us biotest
 
Larry J. Copeland
Consulting or Advisory Role - Celsion; Corcept Therapeutics; Elevar Therapeutics; GlaxoSmithKline; Myriad Genetics; Rubius Therapeutics; Sorrento Therapeutics; Tarveda Therapeutics; Tarveda Therapeutics; Toray Industries
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Macrogenics; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Consulting or Advisory Role - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Merck; Roche/Genentech; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Leslie M. Randall
Honoraria - BluPrint Oncology; Curio Science; PER; Projects in Knowledge; Projects in Knowledge
Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; Eisai; EMD Serono; Genentech/Roche; GOG Foundation; Merck; Mersana; Myriad Genetics; Novartis; Rubius Therapeutics; Seagen
Speakers' Bureau - AstraZeneca; Merck; Tesaro
Research Funding - Aivita Biomedical (Inst); Akeso Biopharma (Inst); AstraZeneca (Inst); GEICO (Inst); Genentech/Roche (Inst); Merck (Inst); On Target Laboratories (Inst); Pfizer (Inst); Tesaro (Inst)